| Literature DB >> 32677975 |
Qingsong Wu1, Jiahui Li1, Liangwan Chen2, Liang Liang Yan1, Zhihuang Qiu1, Yue Shen1, Xianbiao Xie1, Linfeng Xie3.
Abstract
BACKGROUND: We studied early poor postoperative prognosis in acute Stanford type A aortic dissection (ATAAD) patients and investigated the predictive effect of interleukin-6 (IL-6) combined with D-dimer in the early poor postoperative prognosis after ATAAD.Entities:
Keywords: Acute Stanford a aortic dissection; D-dimer; Interleukin-6; Predictive value; Prognostic factor
Mesh:
Substances:
Year: 2020 PMID: 32677975 PMCID: PMC7364558 DOI: 10.1186/s13019-020-01206-y
Source DB: PubMed Journal: J Cardiothorac Surg ISSN: 1749-8090 Impact factor: 1.637
Classification of Surgical complications
| Grade Defifinition | |
|---|---|
Grade I Any deviation from the normal postoperative course without the need for pharmacological treatment or surgical, endoscopic, and radiological interventions Allowed therapeutic regimens are: drugs as antiemetics, antipyretics, analgetics, diuretics, electrolytes, and physiotherapy. This grade also includes wound infections opened at the bedside | |
Grade II Requiring pharmacological treatment with drugs other than such allowed for grade I complications Blood transfusions and total parenteral nutrition are also included | |
| Grade III Requiring surgical, endoscopic or radiological intervention | |
| Grade IIIa Intervention not under general anesthesia | |
| Grade IIIb Intervention under general anesthesia | |
| Grade IV Life-threatening complication (including CNS complications)a requiring IC/ICU management | |
| Grade IVa Single organ dysfunction (including dialysis) | |
| Grade IVb Multiorgan dysfunction | |
| Grade V Death of a patient |
CNS central nervous system, IC intermediate care, ICU intensive care unit
aBrain hemorrhage, ischemic stroke, subarrachnoidal bleeding, but excluding transient ischemic attacks
Preoperative data on the two patient group
| Valuables | Group A ( | Group B ( | |
|---|---|---|---|
| Male, n (%) | 80 (74.8) | 25 (73.5) | 0.885 |
| Age,n (year) | 51.6 ± 10.6 | 50.6 ± 11.9 | 0.660 |
| BMI (Kg/Mˆ2) | 25.8 ± 3.9 | 25.6 ± 4.2 | 0.754 |
| IL-6(pg/mL) | 57.8 ± 39.0 | 211.0 ± 153.7 | |
| D-dimer (ug/mL) | 7.3 ± 6.1 | 16.7 ± 5.8 | |
| Leukocyte(10ˆ9/L) | 12.3 ± 4.0 | 12.8 ± 4.7 | 0.540 |
| Neutrophile granulocyte(10ˆ9/L) | 10.3 ± 3.9 | 10.8 ± 4.3 | 0.553 |
| Leukomonocyte (10ˆ9/L) | 1.1 ± 0.5 | 1.1 ± 0.6 | 0.924 |
| PT (sec) | 15.7 ± 13.7 | 15.7 ± 4.9 | 0.982 |
| Heamoglobin(g/L) | 129.5 ± 23.6 | 126.7 ± 23.3 | 0.553 |
| Albumin(g/L) | 37.3 ± 5.4 | 35.4 ± 4.6 | 0.056 |
| Troponin-I (ug/L) | 0.3 ± 1.0 | 1.9 ± 6.5 | 0.158 |
| NT-ProBNP (pg/mL) | 704.1 ± 1156.7 | 1993.0 ± 6129.2 | 0.231 |
| Serum creatinine (umol/L) | 93.1 ± 42.4 | 136.5 ± 127.7 | 0.060 |
| Lactic acid (mmol/L) | 2.0 ± 1.3 | 1.6 ± 1.3 | 0.178 |
| Alanine aminotransferase (IU/L) | 63.0 ± 169.8 | 166.5 ± 473.0 | 0.219 |
| Aspartate aminotransferase (IU/L) | 69.0 ± 226.2 | 190.4 ± 456.3 | 0.145 |
| EF (%) | 63.8 ± 7.0 | 62.7 ± 6.2 | 0.371 |
| Marfan Syndrome, n (%) | 5 (4.7) | 2 (5.9%) | 0.865 |
| Hypertension, n (%) | 79 (73.8) | 30 (88.2) | 0.080 |
| Diabetes, n (%) | 9 (8.4) | 1 (2.9) | 0.485 |
| Pericardial effusion (Medium or above), n (%) | 5 (4.7) | 4 (11.8) | 0.715 |
| MPS, n (%) | 7 (6.5) | 4 (11.8) | 0.534 |
| AR (Medium or above), n (%) | 28 (26.2) | 7 (20.6) | 0.512 |
| History of cardiac surgery, n (%) | 8 (7.5) | 4 (11.8) | 0.669 |
Continuous normally distributed variables were expressed as mean(±standard deviation) and not-normally distributed variables as medians (interquartile range)
Surgical data on the two patient groups
| Valuables | Group A ( | Group B ( | |
|---|---|---|---|
| Intraoperative time | |||
| Operative time (min) | 302.2 ± 61.8 | 317.1 ± 57.8 | 0.205 |
| CPB time (min) | 148.6 ± 38 | 149.8 ± 38.1 | 0.874 |
| Aortic Clamp time (min) | 49.2 ± 18.9 | 55.7 ± 25.9 | 0.187 |
| SBP time (min) | 9.6 ± 3.2 | 10.1 ± 4.3 | 0.474 |
| CA time (min) | 2.8 ± 0.8 | 3.2 ± 1.3 | 0.155 |
| Aortic Root Concomitant procedure | |||
| Bentall,n(%) | 24 (22.4) | 6 (17.6) | 0.724 |
| AVR,n (%) | 1 (0.9) | 0 (0.0) | 0.544 |
| Cabrol,n(%) | 0 (0.0) | 1 (2.9) | 0.544 |
| CABG,n(%) | 3 (2.8) | 4 (11.8) | 0.100 |
| David,n(%) | 1 (0.9) | 0 (0.0) | 0.544 |
| Sinus forming,n (%) | 47 (43.9) | 10 (29.4) | 0.193 |
Continuous normally distributed variables were expressed as mean (±standard deviation) and not-normally distributed variables as medians (interquartile range)
Diagnostic value of IL-6 and D-dimer for poor postoperative prognosis
| AUC | Cut-off value | 95% CI | ||
|---|---|---|---|---|
| IL-6 (pg/mL) | 0.901 | 108.0 | 0.839 to 0.963 | <0.001 |
| D-dimer (ug/mL) | 0.817 | 14.0 | 0.731 to 0.903 | <0.001 |
| IL-6 + D-dimer | 0.936 | 0.793 to 0.979 | <0.001 |
Fig. 1Distribution of interleukin-6 levels in A and B groups
Fig. 2Distribution of D-dimer levels in A and B groups
Fig. 3Receiver-operating characteristic curve in the prediction of the independent risk factors of early poor postoperative prognosis after Acute Stanford type A aortic dissection
Fig. 4Receiver-operating characteristic curve
Univariate and multivariate analyses for all patients who underwent surgery
| Variable | Univariate Model | Multivariate Model | ||||
|---|---|---|---|---|---|---|
| OR | 95% CI | OR | 95% CI | |||
| < 60 | REF | |||||
| ≥ 60 | 1.016 | 0.423–2.438 | 0.885 | |||
| <25 | REF | |||||
| ≥ 25 | 0.621 | 0.286–1.349 | 0.228 | |||
| Female | REF | |||||
| Male | 1.067 | 0.443–2.566 | 0.885 | |||
| ≤ 108 | REF | REF | ||||
| >108 | 33.662 | 11.906–95.178 | 24.937 | 6.837–90.931 | ||
| ≤ 14.0 | REF | REF | ||||
| >14.0 | 24.706 | 8.884–68.705 | 18.757 | 5.094–69.075 | ||
| ≤ 15.0 | REF | REF | ||||
| > 15.0 | 2.667 | 1.12–6.346 | 1.198 | 0.268–5.350 | 0.813 | |
| ≤ 10 | REF | |||||
| >10 | 0.979 | 0.419–2.285 | 0.961 | |||
| ≤ 7.0 | REF | |||||
| >7.0 | 0.942 | 0.361–2.456 | 0.942 | |||
| ≤ 0.8 | REF | |||||
| >0.8 | 0.545 | 0.241–1.235 | 0.146 | |||
| ≥ 120 | REF | |||||
| <120 | 0.77 | 0.326–1.820 | 0.552 | |||
| ≥ 35.0 | REF | |||||
| <35.0 | 0.565 | 0.256–1.427 | 0.157 | |||
| ≤ 0.02 | REF | |||||
| >0.02 | 1.229 | 0.568–2.662 | 0.601 | |||
| ≤ 349 | REF | |||||
| >349 | 1.442 | 0.663–3.135 | 0.356 | |||
| ≤ 135 | REF | REF | ||||
| >135 | 1.965 | 0.493–7.829 | 0.338 | |||
| Lactic acid (mmol/L) | ||||||
| ≤ 2.5 | REF | |||||
| >2.5 | 2.287 | 0.735–7.116 | 0.153 | |||
| Alanine aminotransferase (IU/L) | ||||||
| ≤ 40 | REF | |||||
| >40 | 0.650 | 0.285–1.483 | 0.306 | |||
| Aspartate aminotransferase (IU/L) | ||||||
| ≤ 46 | REF | |||||
| >46 | 0.605 | 0.258–1.415 | 0.246 | |||
| ≥ 60.0 | REF | |||||
| <60.0 | 1.128 | 0.431–2.954 | 0.807 | |||
| no | REF | |||||
| yes | 1.275 | 0.236–6.891 | 0.778 | |||
| no | REF | |||||
| yes | 2.469 | 0.505–12.080 | 0.265 | |||
| no | REF | |||||
| yes | 0.33 | 0.040–2.703 | 0.302 | |||
| no | REF | |||||
| yes | 3.281 | 0.444–24.234 | 0.244 | |||
| no | REF | |||||
| yes | 1.877 | 0.583–6.043 | 0.291 | |||
| no | REF | |||||
| yes | 0.731 | 0.287–1.866 | ||||
| no | REF | |||||
| yes | 1.65 | 0.464–5.863 | 0.439 | |||
| ≤ 306 | REF | REF | ||||
| >306 | 3.635 | 0.977–13.521 | 0.054 | |||
| ≤ 149 | REF | |||||
| >149 | 0.894 | 0.409–1.952 | 0.779 | |||
| ≤ 51 | REF | |||||
| >51 | 1.324 | 0.601–2.920 | 0.486 | |||
| ≤ 9.7 | REF | |||||
| >9.7 | 1.037 | 0.468–2.296 | 0.929 | |||
| ≤ 3.1 | REF | |||||
| >3.1 | 1.121 | 0.489–2.568 | 0.787 | |||
| no | REF | |||||
| yes | 0.659 | 0.294–1.478 | 0.312 | |||